122 related articles for article (PubMed ID: 10534069)
1. Antisense oligonucleotide of tissue inhibitor of metalloproteinase-1 induces the plasminogen activator activity in periodontal ligament cells.
Shibata Y; Takiguchi H; Abiko Y
J Periodontol; 1999 Oct; 70(10):1158-65. PubMed ID: 10534069
[TBL] [Abstract][Full Text] [Related]
2. Ascorbic acid induces collagenase-1 in human periodontal ligament cells but not in MC3T3-E1 osteoblast-like cells: potential association between collagenase expression and changes in alkaline phosphatase phenotype.
Shiga M; Kapila YL; Zhang Q; Hayami T; Kapila S
J Bone Miner Res; 2003 Jan; 18(1):67-77. PubMed ID: 12510807
[TBL] [Abstract][Full Text] [Related]
3. Regulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases by basic fibroblast growth factor and dexamethasone in periodontal ligament cells.
Hakki SS; Hakki EE; Nohutcu RM
J Periodontal Res; 2009 Dec; 44(6):794-802. PubMed ID: 19602122
[TBL] [Abstract][Full Text] [Related]
4. Plasminogen activation by fibroblasts from periodontal ligament and gingiva is not directly affected by chemokines in vitro.
Sarajlic J; Agis H; Kandler B; Watzek G; Gruber R
Arch Oral Biol; 2007 Jul; 52(7):663-8. PubMed ID: 17296163
[TBL] [Abstract][Full Text] [Related]
5. Regulation of plasminogen activation, matrix metalloproteinases and urokinase-type plasminogen activator-mediated extracellular matrix degradation in human osteosarcoma cell line MG63 by interleukin-1 alpha.
de Bart AC; Quax PH; Löwik CW; Verheijen JH
J Bone Miner Res; 1995 Sep; 10(9):1374-84. PubMed ID: 7502710
[TBL] [Abstract][Full Text] [Related]
6. Independent regulation of matrix metalloproteinases and plasminogen activators in human fibrosarcoma cells.
Lim YT; Sugiura Y; Laug WE; Sun B; Garcia A; DeClerck YA
J Cell Physiol; 1996 May; 167(2):333-40. PubMed ID: 8613475
[TBL] [Abstract][Full Text] [Related]
7. Short chain fatty acids inhibit human (SW1116) colon cancer cell invasion by reducing urokinase plasminogen activator activity and stimulating TIMP-1 and TIMP-2 activities, rather than via MMP modulation.
Emenaker NJ; Basson MD
J Surg Res; 1998 Apr; 76(1):41-6. PubMed ID: 9695737
[TBL] [Abstract][Full Text] [Related]
8. The effect of IL-1alpha on the expression of matrix metalloproteinases, plasminogen activators, and their inhibitors in osteoblastic ROS 17/2.8 cells.
Fujisaki K; Tanabe N; Suzuki N; Mitsui N; Oka H; Ito K; Maeno M
Life Sci; 2006 Mar; 78(17):1975-82. PubMed ID: 16313928
[TBL] [Abstract][Full Text] [Related]
9. Increased TIMP/MMP ratio in varicose veins: a possible explanation for extracellular matrix accumulation.
Badier-Commander C; Verbeuren T; Lebard C; Michel JB; Jacob MP
J Pathol; 2000 Sep; 192(1):105-12. PubMed ID: 10951407
[TBL] [Abstract][Full Text] [Related]
10. Enamel matrix derivative induces the expression of tissue inhibitor of matrix metalloproteinase-3 in human gingival fibroblasts via extracellular signal-regulated kinase.
Zeldich E; Koren R; Dard M; Weinberg E; Weinreb M; Nemcovsky CE
J Periodontal Res; 2010 Apr; 45(2):200-6. PubMed ID: 19909407
[TBL] [Abstract][Full Text] [Related]
11. ECM degradation by cultured human mesangial cells is mediated by a PA/plasmin/MMP-2 cascade.
Baricos WH; Cortez SL; el-Dahr SS; Schnaper HW
Kidney Int; 1995 Apr; 47(4):1039-47. PubMed ID: 7540230
[TBL] [Abstract][Full Text] [Related]
12. In vitro effects of interleukin 1 on the synthesis of metalloproteases, TIMP, plasminogen activators and inhibitors in human articular cartilage.
Martel-Pelletier J; Zafarullah M; Kodama S; Pelletier JP
J Rheumatol Suppl; 1991 Feb; 27():80-4. PubMed ID: 1851231
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor beta inhibits plasminogen activator (PA) activity and stimulates production of urokinase-type PA, PA inhibitor-1 mRNA, and protein in rat osteoblast-like cells.
Allan EH; Zeheb R; Gelehrter TD; Heaton JH; Fukumoto S; Yee JA; Martin TJ
J Cell Physiol; 1991 Oct; 149(1):34-43. PubMed ID: 1834680
[TBL] [Abstract][Full Text] [Related]
14. Platelet-activating factor induces the gene expression of TIMP-1, -2, and PAI-1: imbalance between the gene expression of MMP-9 and TIMP-1 and -2.
Ottino P; Taheri F; Bazan HE
Exp Eye Res; 2002 Mar; 74(3):393-402. PubMed ID: 12014920
[TBL] [Abstract][Full Text] [Related]
15. The expression of plasminogen activator system in a rat model of periodontal wound healing.
Xiao Y; Li H; Bunn C; Bartold PM
J Periodontol; 2001 Jul; 72(7):849-57. PubMed ID: 11495131
[TBL] [Abstract][Full Text] [Related]
16. Brain-derived neurotrophic factor inducing angiogenesis through modulation of matrix-degrading proteases.
Sun CY; Hu Y; Wang HF; He WJ; Wang YD; Wu T
Chin Med J (Engl); 2006 Apr; 119(7):589-95. PubMed ID: 16620701
[TBL] [Abstract][Full Text] [Related]
17. Expression of matrix metalloproteinase-1, matrix metalloproteinase-2 and extracellular metalloproteinase inducer in human periodontal ligament cells stimulated with interleukin-1 beta.
Xiang J; Li C; Dong W; Cao Z; Liu L
J Periodontal Res; 2009 Dec; 44(6):784-93. PubMed ID: 19602123
[TBL] [Abstract][Full Text] [Related]
18. Melatonin inhibits postischemic matrix metalloproteinase-9 (MMP-9) activation via dual modulation of plasminogen/plasmin system and endogenous MMP inhibitor in mice subjected to transient focal cerebral ischemia.
Tai SH; Chen HY; Lee EJ; Chen TY; Lin HW; Hung YC; Huang SY; Chen YH; Lee WT; Wu TS
J Pineal Res; 2010 Nov; 49(4):332-41. PubMed ID: 20663046
[TBL] [Abstract][Full Text] [Related]
19. Effects of bisphosphonate on matrix metalloproteinase enzymes in human periodontal ligament cells.
Nakaya H; Osawa G; Iwasaki N; Cochran DL; Kamoi K; Oates TW
J Periodontol; 2000 Jul; 71(7):1158-66. PubMed ID: 10960024
[TBL] [Abstract][Full Text] [Related]
20. Plasmin activates pro-matrix metalloproteinase-2 with a membrane-type 1 matrix metalloproteinase-dependent mechanism.
Monea S; Lehti K; Keski-Oja J; Mignatti P
J Cell Physiol; 2002 Aug; 192(2):160-70. PubMed ID: 12115722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
